Potjewyd, F. M., Annor‐Gyamfi, J. K., Aubé, J., Chu, S., Conlon, I. L., Frankowski, K. J., Guduru, S. K. R., Hardy, B. P., Hopkins, M. D., Kinoshita, C., Kireev, D. B., Mason, E. R., Moerk, C. T., Nwogbo, F., Pearce, K. H., Richardson, T. I., Rogers, D. A., Soni, D. M., Stashko, M., Wang, X., Wells, C., Willson, T. M., Frye, S. V., Young, J. E., & Axtman, A. D. (2022). use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology. Alzheimer's & dementia, 8(1), n/a. http://access.bl.uk/ark:/81055/vdc_100173098308.0x000008